Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics

Viewer control panel                    

Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.

Results:

Download Network (json)

Download results

Data source: DrugBank-all; Query type: target; # of requested predictions: 20; Secondary interactions: no
Input target 1: P01024

No.	Gene	UniProt ID	Protein Name	Pathway	PDB
1	C3	P01024	Complement C3	hsa04145; hsa04610; hsa05133; hsa05134; hsa05140; hsa05142; hsa05150; hsa05152; hsa05167; hsa05168; hsa05203; hsa05322	1C3D; 1GHQ; 1W2S; 2A73; 2A74; 2GOX; 2HR0; 2I07; 2ICE; 2ICF; 2NOJ; 2QKI; 2WII; 2WIN; 2WY7; 2WY8; 2XQW; 2XWB; 2XWJ; 3D5R; 3D5S; 3G6J; 3L3O; 3L5N; 3NMS; 3OED; 3OHX; 3OXU; 3RJ3; 3T4A; 4HW5; 4HWJ; 4I6O; 4M76; 4ONT

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter	Image
1	Approved; Investigational	SmallMoleculeDrug	DB01593	Zinc	[Zn]
2	Approved; Investigational	SmallMoleculeDrug	DB09130	Copper	[Cu]
3	Experimental	SmallMoleculeDrug	DB01915	S-Hydroxycysteine	N[C@@H](CSO)C(O)=O
4	Approved; Investigational	BiotechDrug	DB00028	Immune Globulin Human	NA
5	Investigational	BiotechDrug	DB06492	Mirococept	NA

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter	Image	Confidence score
1	Approved; Nutraceutical	SmallMoleculeDrug	DB00142	Glutamic Acid	N[C@@H](CCC(O)=O)C(O)=O		32.4%
2	Approved	BiotechDrug	DB00054	Abciximab	NA		25.5%
3	Approved; Investigational	BiotechDrug	DB01257	Eculizumab	NA		23.9%
4	Approved; Investigational	BiotechDrug	DB00075	Muromonab	NA		23.9%
5	Approved; Investigational	BiotechDrug	DB00056	Gemtuzumab ozogamicin	NA		22.3%
6	Approved; Investigational	BiotechDrug	DB00095	Efalizumab	NA		20.1%
7	Approved	BiotechDrug	DB00098	Antithymocyte immunoglobulin (rabbit)	NA		20.1%
8	Approved; Nutraceutical; Vet approved	SmallMoleculeDrug	DB00145	Glycine	NCC(O)=O		20.0%
9	Approved; Investigational	BiotechDrug	DB00072	Trastuzumab	NA		20.0%
10	Investigational; Withdrawn	BiotechDrug	DB00111	Daclizumab	NA		19.5%
11	Approved	BiotechDrug	DB00002	Cetuximab	NA		19.2%
12	Approved	SmallMoleculeDrug	DB11093	Calcium Citrate	[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O		19.2%
13	Experimental	SmallMoleculeDrug	DB03814	2-(N-Morpholino)-Ethanesulfonic Acid	[O-]S(=O)(=O)CC[NH+]1CCOCC1		19.1%
14	Approved; Investigational	BiotechDrug	DB00078	Ibritumomab tiuxetan	NA		19.1%
15	Approved; Experimental	SmallMoleculeDrug	DB03796	Palmitic Acid	CCCCCCCCCCCCCCCC(O)=O		18.5%
16	Approved; Investigational	BiotechDrug	DB00005	Etanercept	NA		17.7%
17	Approved; Investigational; Nutraceutical	SmallMoleculeDrug	DB00141	N-Acetylglucosamine	[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO		17.7%
18	Approved; Investigational	BiotechDrug	DB06372	Rilonacept	NA		17.3%
19	Approved; Investigational	BiotechDrug	DB00074	Basiliximab	NA		17.1%
20	Approved; Investigational	BiotechDrug	DB11767	Sarilumab	NA		17.0%